Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

2.6%

1 terminated/withdrawn out of 38 trials

Success Rate

94.7%

+8.2% vs industry average

Late-Stage Pipeline

32%

12 trials in Phase 3/4

Results Transparency

0%

0 of 18 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

Phase 4
10(41.7%)
Phase 2
5(20.8%)
N/A
5(20.8%)
Phase 3
2(8.3%)
Phase 1
2(8.3%)
24Total
Phase 4(10)
Phase 2(5)
N/A(5)
Phase 3(2)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (38)

Showing 20 of 38 trials
NCT07433855Not ApplicableCompleted

Efficacy and Safety of Heat-Treated Lactiplantibacillus Plantarum LM1004 on Immune Function

Role: lead

NCT06637943Not Yet Recruiting

Comparison of the Diagnosis Time of VET and SCL in Patients With Intraoperative Coagulopathy

Role: collaborator

NCT06124833Recruiting

Omics-driven Research on the Gut-Oral Microbiome, Metabolome, Lifestyle, and Clinical Integration in Korean Inflammatory Bowel Disease

Role: collaborator

NCT04749888Not ApplicableActive Not Recruiting

Impact of the Korea Early Childhood Home-visiting Intervention

Role: collaborator

NCT05255588Completed

A Stool DNA-based SDC2 Methylation Test for the Early Detection of Colorectal Cancer

Role: collaborator

NCT01518556Phase 1Completed

Safety and Efficacy Study of Idarubicin Dose Intensification to Treat Acute Myeloid Leukemia

Role: collaborator

NCT05992220Phase 2Recruiting

Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Invasion

Role: collaborator

NCT06706050Phase 1Completed

Clinical Therapeutic Potential of Novel Microbiome LP-51 on Xerosis Individual Based on Xerosis-microbiome Index

Role: collaborator

NCT05957822Phase 4Recruiting

Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery

Role: collaborator

NCT05381194Phase 4Recruiting

BPaL(M) Regimen for the Treatment of MDR/RR-TB

Role: collaborator

NCT06075160Recruiting

Resting Full-cycle Ratio (RFR)-Guided Revascularization

Role: collaborator

NCT06075173Unknown

Resting Full-cycle Ratio in Side Branch

Role: collaborator

NCT05978882Not ApplicableNot Yet Recruiting

Feasibility Study of Sentinel Navigation Surgery in Early Gastric Cancer Using Fluorescence (SENORITA4)

Role: collaborator

NCT05746416Completed

Xience Registry In Complex Lesion of Acute Coronary Syndrome Patients witH Ticagrelor (RICH)

Role: collaborator

NCT03042520Unknown

Long-term Outcomes of Chronic Hepatitis C Patients Post Sofosbuvir-based Treatment

Role: collaborator

NCT03433235Phase 2Completed

Early Administration of Edoxaban After Acute Ischemic Stroke in Patients With Non-valvular Atrial Fibrillation

Role: collaborator

NCT01850368Phase 2Completed

Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein Invasion

Role: collaborator

NCT03597633Unknown

Tenofovir Combination or Mono-therapy for MDR CHB

Role: collaborator

NCT01543724Phase 4Withdrawn

Neural Correlates for Therapeutic Mechanisms of Lithium in Bipolar Disorder

Role: collaborator

NCT01141088Not ApplicableUnknown

Two Bilateral Metal Stenting in Hilar Malignancy

Role: lead